دورية أكاديمية
Low IgA Associated With Oropharyngeal Microbiota Changes and Lung Disease in Primary Antibody Deficiency.
العنوان: | Low IgA Associated With Oropharyngeal Microbiota Changes and Lung Disease in Primary Antibody Deficiency. |
---|---|
المؤلفون: | Berbers RM; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands., Mohamed Hoesein FAA; Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands., Ellerbroek PM; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands., van Montfrans JM; Department of Paediatric Immunology and Infectious Diseases, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands., Dalm VASH; Division of Clinical Immunology, Department of Internal Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands.; Department of Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands.; Academic Center for Rare Immunological Diseases (RIDC), Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands., van Hagen PM; Division of Clinical Immunology, Department of Internal Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands.; Department of Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands.; Academic Center for Rare Immunological Diseases (RIDC), Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands., Paganelli FL; Department of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands., Viveen MC; Department of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands., Rogers MRC; Department of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands., de Jong PA; Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands., Uh HW; Department of Biostatistics and Research Support, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands., Willems RJL; Department of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands., Leavis HL; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands. |
المصدر: | Frontiers in immunology [Front Immunol] 2020 Jun 19; Vol. 11, pp. 1245. Date of Electronic Publication: 2020 Jun 19 (Print Publication: 2020). |
نوع المنشور: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Research Foundation] |
مواضيع طبية MeSH: | Immunoglobulin A/*immunology , Immunologic Deficiency Syndromes/*complications , Immunologic Deficiency Syndromes/*immunology , Lung Diseases/*immunology , Oropharynx/*microbiology, Adolescent ; Adult ; Child ; Cross-Sectional Studies ; Female ; Humans ; Immunoglobulin A/blood ; Male ; Young Adult |
مستخلص: | Common Variable Immunodeficiency (CVID) and X-linked agammaglobulinemia (XLA) are primary antibody deficiencies characterized by hypogammaglobulinemia and recurrent infections, which can lead to structural airway disease (AD) and interstitial lung disease (ILD). We investigated associations between serum IgA, oropharyngeal microbiota composition and severity of lung disease in these patients. In this cross-sectional multicentre study we analyzed oropharyngeal microbiota composition of 86 CVID patients, 12 XLA patients and 49 healthy controls (HC) using next-generation sequencing of the 16S rRNA gene. qPCR was used to estimate bacterial load. IgA was measured in serum. High resolution CT scans were scored for severity of AD and ILD. Oropharyngeal bacterial load was increased in CVID patients with low IgA ( p = 0.013) and XLA ( p = 0.029) compared to HC. IgA status was associated with distinct beta (between-sample) diversity ( p = 0.039), enrichment of ( Allo)prevotella , and more severe radiographic lung disease ( p = 0.003), independently of recent antibiotic use. AD scores were positively associated with Prevotella, Alloprevotella , and Selenomonas , and ILD scores with Streptococcus and negatively with Rothia . In clinically stable patients with CVID and XLA, radiographic lung disease was associated with IgA deficiency and expansion of distinct oropharyngeal bacterial taxa. Our findings highlight IgA as a potential driver of upper respiratory tract microbiota homeostasis. (Copyright © 2020 Berbers, Mohamed Hoesein, Ellerbroek, van Montfrans, Dalm, van Hagen, Paganelli, Viveen, Rogers, de Jong, Uh, Willems and Leavis.) |
References: | mBio. 2015 Mar 03;6(2):e00037. (PMID: 25736890) J Clin Immunol. 2012 Oct;32(5):907-21. (PMID: 22526591) Int Immunopharmacol. 2004 Jun;4(6):745-53. (PMID: 15135316) Clin Immunol. 2002 Sep;104(3):221-30. (PMID: 12217331) Clin Immunol. 2006 Feb-Mar;118(2-3):201-8. (PMID: 16377251) J Autoimmun. 2019 Mar;98:132-148. (PMID: 30704941) Philos Trans R Soc Lond B Biol Sci. 2015 Aug 19;370(1675):. (PMID: 26150660) FEMS Microbiol Lett. 2000 Sep 1;190(1):73-9. (PMID: 10981693) Microbiome. 2016 Jul 07;4(1):37. (PMID: 27388563) J Clin Immunol. 2014 Aug;34(6):642-54. (PMID: 24952009) Am J Respir Crit Care Med. 2013 May 15;187(10):1118-26. (PMID: 23348972) Clin Radiol. 2012 Jun;67(6):587-95. (PMID: 22226567) J Allergy Clin Immunol. 2017 Mar;139(3):826-834.e13. (PMID: 27576124) Mucosal Immunol. 2016 Nov;9(6):1455-1465. (PMID: 26982597) J Allergy Clin Immunol. 2004 Aug;114(2):415-21. (PMID: 15316526) Nat Methods. 2016 Jul;13(7):581-3. (PMID: 27214047) J Allergy Clin Immunol. 2017 Jul;140(1):303-306.e4. (PMID: 28126376) Front Microbiol. 2017 Nov 07;8:2114. (PMID: 29163406) J Clin Immunol. 2007 May;27(3):308-16. (PMID: 17510807) Respir Res. 2017 Feb 1;18(1):29. (PMID: 28143484) J Innate Immun. 2017;9(3):281-299. (PMID: 28052300) Elife. 2013 Nov 05;2:e01202. (PMID: 24192039) Microbiome. 2014 Feb 24;2(1):6. (PMID: 24558975) Front Microbiol. 2017 Nov 15;8:2224. (PMID: 29187837) Blood. 2012 Feb 16;119(7):1650-7. (PMID: 22180439) Thorax. 2013 Aug;68(8):731-7. (PMID: 23564400) ISME J. 2016 Jan;10(1):97-108. (PMID: 26151645) Nat Commun. 2019 Dec 16;10(1):5714. (PMID: 31844063) Immunity. 2019 Mar 19;50(3):692-706.e7. (PMID: 30824326) Microb Ecol. 2010 Oct;60(3):677-90. (PMID: 20614117) Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6. (PMID: 23193283) Sci Transl Med. 2018 May 2;10(439):. (PMID: 29720448) Eur Respir J. 2017 Dec 14;50(6):. (PMID: 29242257) Arthritis Res Ther. 2012 Sep 24;14(5):223. (PMID: 23043756) Chest. 2010 Aug;138(2):371-9. (PMID: 20299624) Am J Respir Crit Care Med. 2014 Oct 15;190(8):906-13. (PMID: 25184687) Immunity. 2018 Aug 21;49(2):211-224. (PMID: 30134201) PLoS One. 2014 Jul 11;9(7):e102045. (PMID: 25013895) Cell. 2014 Aug 28;158(5):1000-1010. (PMID: 25171403) Lancet Respir Med. 2014 Jul;2(7):548-56. (PMID: 24767767) Curr Opin Allergy Clin Immunol. 2019 Dec;19(6):563-570. (PMID: 31389816) J Allergy Clin Immunol. 2020 Mar 10;:. (PMID: 32169379) J Allergy Clin Immunol. 2011 Feb;127(2):372-381.e1-3. (PMID: 21194740) J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):938-945. (PMID: 28351785) PLoS One. 2010 Jan 05;5(1):e8578. (PMID: 20052417) J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):38-59. (PMID: 26563668) Nature. 1993 Jan 21;361(6409):226-33. (PMID: 8380905) Clin Exp Immunol. 2017 Jan;187(1):138-145. (PMID: 27896807) Curr Opin Pulm Med. 2017 Sep;23(5):404-410. (PMID: 28650861) Nat Biotechnol. 2019 Aug;37(8):852-857. (PMID: 31341288) BMC Microbiol. 2012 Apr 17;12:56. (PMID: 22510143) |
فهرسة مساهمة: | Keywords: CVID; XLA; immunoglobulin A; lung disease; microbiota; oropharyngeal |
المشرفين على المادة: | 0 (Immunoglobulin A) |
تواريخ الأحداث: | Date Created: 20200709 Date Completed: 20210405 Latest Revision: 20210405 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC7318304 |
DOI: | 10.3389/fimmu.2020.01245 |
PMID: | 32636843 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1664-3224 |
---|---|
DOI: | 10.3389/fimmu.2020.01245 |